Valeant Pharmaceuticals International Inc (VRX.TO) set a deadline for its unsolicited $5.7 billion bid for Cephalon Inc (CEPH.O), saying it will move on if more than 50 percent of Cephalon shareholders do not consent to the offer by May 12. The Canadian drugmaker issued its deadline in a letter to Cephalon shareholders on Thursday.
Source
